Gilead Sciences, Inc. (GILD) — Stock Score Summary

Gilead Sciences, Inc. (GILD) has a MoatMap StockRank of 96/100 based on Quality (75/100), Value (47/100), and Momentum (65/100) factor scores. The current signal is STRONG BUY. Gilead Sciences is a large-cap biotech giant with strong cash flows from its HIV franchise. However, it is not a CDMO and does not benefit from the high-growth pricing power cycle we have identified in contract manufacturing.

Gilead Sciences, Inc. is a biopharmaceutical company dedicated to the research, development, and commercialization of innovative medicines, predominantly in antiviral therapies for HIV and Hepatitis, as well as oncology and inflammatory diseases. The company maintains a dominant market position in its core antiviral franchises through proprietary drugs and a strong R&D pipeline, while strategically expanding into new therapeutic areas.

Key Financial Metrics

Price$129.18
Market Cap$169.1B
P/E (TTM)17.58
P/E (Forward)13.48
Price/Book6.82
Return on Equity43.4%
Return on Invested Capital22.9%
Debt/Equity94.64
Gross Margin79.4%
Operating Margin39.3%
Revenue Growth4.4%
Dividend Yield2.5%
Free Cash Flow$7.9B

Gilead Sciences, Inc. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Gilead Sciences, Inc.’s (GILD) StockRank?
MoatMap’s StockRank for Gilead Sciences, Inc. (GILD) is 96/100, with a Strong Buy signal. It is a composite of Quality (75), Value (47), and Momentum (65) factor ranks across MoatMap’s 19,000+ stock universe.
Does Gilead Sciences, Inc. have an economic moat?
Gilead Sciences, Inc. (GILD) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Gilead Sciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Gilead Sciences, Inc. (GILD) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Gilead Sciences, Inc. in?
Gilead Sciences, Inc. (GILD) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (United States).
Browse all ranked stocksGILD deep dive reportAI ChampionsHow we score stocksSense-check another stock